HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
VISION
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
NTx®-265 (Stroke)
NTx®-428 (Brain Trauma)
NTx®-488 (Multiple Sclerosis)
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
INVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
TSX - Venture:
SSS
OUR TECHNOLOGY
STROKE
TRAUMATIC BRAIN INJURY
MULTIPLE SCLEROSIS
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
MEDIA CENTRE
Dr. Alan Moore plays guitar at Florida International University
First Musical piece played: Choros No.1 by Villa-Lobos
0:00
Dr. Alan Moore plays guitar at Florida International University
Second Musical piece played: Seranata Espanola by Malats
0:00
Stem Cell Therapeutics Highlighted on BTV
Dr. Alan Moore, President & CEO interviewed on BTV segment.
3:52
Stem Cell Therapeutics in the News
BNN Power Breakfast Interview with Dr. Alan Moore, President & CEO
5:46
Stem Cell Therapeutics in the News
Stem Cell Therapeutics featured on CBC News (June, 2007)
3:05
A Second Chance
Interview with Dr. Steven Cramer, M.D, NTxTM-265 Stroke STudy Principal Investigator.
7:51
Noninvasive Regeneration of Adult Neural Stem Cells
Animation highlighting Stem Cell Therapeutics Lead program NTxTM-265 for treatment of Strokes.
2:18
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.065
Change:
+8.33%
Volume:
243549
Date:
9/3/2010
Time:
3:48pm
Note: Quotes are delayed. For informational purposes only.
LETTER TO SHAREHOLDERS
+
2009 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us